. Moderna’s Covid-19 vaccine shows 93% efficacy through 6 months, as company expects to finish application for approval this month « JO LEE MAGAZINE

CNN – The efficacy data came from a final analysis of the vaccine’s Phase 3 study, which enrolled thousands of participants who received both doses last year, before it was made available to the wider public. “In final analysis” of the study, “the Moderna Covid-19 vaccine showed 93% efficacy, with the efficacy remaining durable through six months after administration of the second dose,” Moderna said in a news release. The data reflecting 93% efficacy was from trial participants who had been fully vaccinated by November 25 and evaluated for the following six months, before the highly contagious Delta variant became dominant in the United States and spurred the current surge in cases.

Comments are closed.